Clinical trial
Nicardipine Versus Esmolol for Management of Emergence Hypertension After Craniotomy
NCT01951950 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nicardipine Versus Esmolol for Management of Emergence Hypertension After Craniotomy
- Lead sponsor
- Northwestern University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 30, 2013
- Completion date
- May 31, 2014
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brain tumors